CuraSen Therapeutics, Inc. — Form D/A
CuraSen Therapeutics, Inc. of San Carlos, CA, a company, filed a Form D amendment with the SEC on 2023-10-12. The offering totals $20.8M, of which $17.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-12
- Form: D/A
- Accession: 0001567619-23-007439
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.8M
- Amount sold: $17.6M
- Remaining: $3.2M
- Investors: 11
- Date of first sale: 2022-11-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-464469
Issuer
- Name: CuraSen Therapeutics, Inc.
- CIK: 0001765883
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 733 Industrial Road, San Carlos, CA, 94070
- Phone: 650-475-2842
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Simon Sereda Tate | Director | San Carlos, CA |
| Ron Sereda Hunt | Director | San Carlos, CA |
| Benjamin Sereda Potter | Executive Officer | Menlo Park, CA |
| Loretta Sereda Tse, Ph.D. | Director | San Carlos, CA |
| Kathleen Sereda Glaub | Director | San Carlos, CA |
| Simon Sereda Tate, Ph.D. | Director | San Carlos, CA |
| Patrick Sereda Enright | Director | San Carlos, CA |
| Anthony P Ford | Director | San Carlos, CA |
| Anthony P Ford | Executive Officer | San Carlos, CA |
| Henry Sereda Skinner | Director | San Mateo, CA |
| Liam Sereda Ratcliffe | Director | San Mateo, CA |
Other filings by this issuer (4)
More